US 12,441,757 B2
Platform for screening NAD+ binding proteins in a cellular context
Michael Cohen, Portland, OR (US); and Sunil K. Sundalam, Portland, OR (US)
Assigned to Oregon Health & Science University, Portland, OR (US)
Appl. No. 17/926,979
Filed by OREGON HEALTH & SCIENCE UNIVERSITY, Portland, OR (US)
PCT Filed Jun. 18, 2021, PCT No. PCT/US2021/038072
§ 371(c)(1), (2) Date Nov. 21, 2022,
PCT Pub. No. WO2021/262548, PCT Pub. Date Dec. 30, 2021.
Claims priority of provisional application 63/179,832, filed on Apr. 26, 2021.
Claims priority of provisional application 63/042,449, filed on Jun. 22, 2020.
Prior Publication US 2023/0212213 A1, Jul. 6, 2023
Int. Cl. C07H 19/207 (2006.01); C12Q 1/32 (2006.01); G01N 33/533 (2006.01); G01N 33/573 (2006.01)
CPC C07H 19/207 (2013.01) [C12Q 1/32 (2013.01); G01N 33/533 (2013.01); G01N 33/5735 (2013.01)] 11 Claims
 
1. A compound selected from the group of:

OG Complex Work Unit Chemistry